New project in collaboration with Ona Therapeutics S.L. (ONA): Generation of a conditionally active antibody-drug conjugate for the treatment of Acute Myeloid Leukemia (AML). It has been funded by the "Nuclis" call for proposals by ACCIO (Generalitat de Catalunya)
